Lantern Pharma's market cap is currently $49.46M. The company's EPS TTM is $-0.4; its P/E ratio is ―; Lantern Pharma is scheduled to report earnings on August 13, 2025, and the estimated EPS forecast is $-0.47. See an overview of income statement, balance sheet, and cash flow financials.
